Frontiers | Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies | Immunology
Plasma exchange and thrombotic microangiopathies: From pathophysiology to clinical practice - ScienceDirect
JCM | Free Full-Text | Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management | HTML
Serum Neutrophil Extracellular Trap Levels Predict Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time? - Cancer Treatment Reviews
الطريق المتقدمة النظرية الأساسية free dna as early marker of thrombotic microangiopathy - sabiduriascolectivas.com
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura - Kidney International
Plasma levels of S100A8/A9, histone/DNA complexes, and cell‐free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura - Sui - 2021 - Journal of Thrombosis and Haemostasis - Wiley Online Library
IJMS | Free Full-Text | Increase of Neutrophil Activation Markers in Venous Thrombosis—Contribution of Circulating Activated Protein C | HTML
Endothelial cell functions impaired by interferon in vitro: Insights into the molecular mechanism of thrombotic microangiopathy associated with interferon therapy - Thrombosis Research
Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? | Bone Marrow Transplantation
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. - Abstract - Europe PMC
Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura* - Journal of Biological Chemistry
VEGF Inhibition and Renal Thrombotic Microangiopathy | NEJM
Thrombotic thrombocytopenic purpura | Nature Reviews Disease Primers
Serum Neutrophil Extracellular Trap Levels Predict Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
A Fatal Case of Thrombotic Microangiopathy Without Schistocytosis and Absent Biochemical Markers of Hemolysis - The American Journal of the Medical Sciences
Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury | Nature Reviews Nephrology
Systemic autoimmune disorders associated with thrombotic microangiopathy: A cross-sectional analysis from the French National TMA registry: Systemic autoimmune disease-associated TMA - European Journal of Internal Medicine
IJMS | Free Full-Text | Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms | HTML
Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers | Haematologica
Frontiers | Extracellular DNA—A Danger Signal Triggering Immunothrombosis | Immunology
